Research graph
References from Troglitazone reduces plasma levels of tumour necrosis factor‐α in obese patients with type 2 diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
TNF‐α‐induced insulin resistance in vivo and its prevention by troglitazone
10.2337/diab.46.11.1678 · 1997 · External reference
10.1172/jci119715
10.1172/jci119715 · External reference
10.1210/jc.83.3.859
10.1210/jc.83.3.859 · External reference
10.1055/s-2007-979001
10.1055/s-2007-979001 · External reference
10.1210/jc.84.1.272
10.1210/jc.84.1.272 · External reference
10.1210/jc.83.8.2907
10.1210/jc.83.8.2907 · External reference
10.1007/bf00280883
10.1007/bf00280883 · External reference
10.2337/diacare.22.6.908
10.2337/diacare.22.6.908 · External reference
10.2337/diacare.21.9.1470
10.2337/diacare.21.9.1470 · External reference
10.1172/jci119824
10.1172/jci119824 · External reference
Advancing age and insulin resistance: role of plasma tumor necrosis factor‐α
1998 · External reference
10.1172/jci1235
10.1172/jci1235 · External reference
